6 months ago
SRPT
AnalystsDanielle BrillDanielle Brill's Stock Forecasts
AnalystsDanielle Brill
Analyst Ranking
Bottom 8%
#4496 out of 4866 analysts
Average Return
-9.26%
Win Rate
31%19 out of 62
Risk vs Reward
Poor
Good
Danielle Brill's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +165.50% | $5.42 | $14.39 | 2024-10-10 - 2025-04-22 | Buy |
Sage Therapeutics IncSAGE | +149.76% | $70.20 | $175.33 | 2017-05-16 - 2018-05-16 | Buy |
Argenx SeARGX | +76.16% | $354.13 | $623.82 | 2023-12-21 - 2024-12-20 | Strong Buy |
Harmony Biosciences Holdings IncHRMY | +48.54% | $23.90 | $35.50 | 2023-10-16 - 2024-10-15 | Buy |
Acceleron Pharma IncXLRN | +48.10% | $79.39 | $117.58 | 2020-01-28 - 2021-01-28 | Strong Buy |
Danielle Brill Analyst Color
Get additional color on Danielle Brill's coverage of popular stocks
Danielle Brill's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Uniqure NvQURE | 6 | Strong Buy | $52.00 | +261.36% | Upgrades | 4 months ago |
Tectonic Therapeutic IncTECX | 1 | Buy | $65.00 | +233.50% | Initiates Coverage On | 5 months ago |
Biomarin Pharmaceutical IncBMRN | 1 | Buy | $79.00 | +28.46% | Reinstates | 6 months ago |
Regenxbio IncRGNX | 1 | Buy | $18.00 | +130.18% | Reinstates | 6 months ago |
Neurocrine Biosciences IncNBIX | 5 | Buy | $155.00 | +52.35% | Reinstates | 6 months ago |
Immunovant IncIMVT | 4 | Buy | $36.00 | +152.63% | Reinstates | 6 months ago |
Harmony Biosciences Holdings IncHRMY | 7 | Buy | $40.00 | +37.08% | Reinstates | 6 months ago |
Sarepta Therapeutics IncSRPT | 2 | Buy | $150.00 | +152.91% | Reinstates | 6 months ago |
Argenx SeARGX | 7 | Strong Buy | $605.00 | +0.86% | Reinstates | 6 months ago |
Xenon Pharmaceuticals IncXENE | 2 | Buy | $50.00 | +36.13% | Reinstates | 6 months ago |
Agios Pharmaceuticals IncAGIO | 2 | Buy | $51.00 | +82.14% | Reinstates | 6 months ago |
Disc Medicine IncIRON | 4 | Buy | $43.00 | -2.29% | Maintains | a year ago |
Biogen IncBIIB | 1 | Buy | $283.00 | N/A | Upgrades | a year ago |
Passage Bio IncPASG | 5 | Buy | $5.00 | N/A | Maintains | a year ago |
Ptc Therapeutics IncPTCT | 6 | Buy | $55.00 | N/A | Maintains | 2 years ago |
Fibrogen IncFGEN | 2 | Buy | $35.00 | N/A | Upgrades | 2 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $35.00 | N/A | Downgrades | 4 years ago |
Global Blood Therapeutics IncGBT | 4 | Hold | $50.00 | N/A | Downgrades | 4 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Zogenix IncZGNX | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Buy | $28.00 | N/A | Assumes | 7 years ago |
Sage Therapeutics IncSAGE | 1 | Buy | $82.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.